A supplier suspends shipping to Italy after 15 consecutive customs detentions
The route did not close because of a rule about peptides.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 2 of 13 of this archive, newest first.
The route did not close because of a rule about peptides.
Efficacy was never the question in this appraisal. Duration of treatment was.
We set out what is known, what is inferred and what is simply assumed about the fortnight after a vial is opened.
The route did not close because of a rule about peptides.
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
We set out what is known, what is inferred and what is simply assumed about the fortnight after a vial is opened.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
Efficacy was never the question in this appraisal. Duration of treatment was.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
Duplicate submissions under different names test within-laboratory repeatability, which is a different quantity from between-laboratory reproducibility.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
Efficacy was never the question in this appraisal. Duration of treatment was.
The route did not close because of a rule about peptides.